SCHEMBL8560466

SCHEMBL8560466

N=C(N)NCCCC(=O)OCc1ccccc1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTT P42858 1/20 0.57
EPHX2 P34913 1/20 0.51
ALDH1A1 P00352 2/20 0.49
MAPK1 P28482 1/20 0.49
L3MBTL1 Q9Y468 1/20 0.49
KMT2A Q03164 3/20 0.48
MEN1 O00255 2/20 0.48
CYP3A4 P08684 1/20 0.48
CYP2D6 P10635 1/20 0.48
CYP2C9 P11712 1/20 0.48
CYP2C19 P33261 1/20 0.48
TPSAB1 Q15661 1/20 0.47
TPSD1 Q9BZJ3 1/20 0.47
TPSG1 Q9NRR2 1/20 0.47
HPGD P15428 1/20 0.46
HSP90AA1 P07900 2/20 0.46
LMNA P02545 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
SLC6A2 P23975 1/20 0.45
SLC6A3 Q01959 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8557693 0.96 EPHX2 (0.56) HTTEPHX2ALDH1A1MAPK1L3MBTL1
SCHEMBL8174680 0.91 ALDH1A1 (0.51) HTTEPHX2ALDH1A1MAPK1L3MBTL1
SCHEMBL24180428 0.88 HTT (0.60) HTTEPHX2ALDH1A1MAPK1L3MBTL1
SCHEMBL20362125 0.84 HTT (0.56) HTTEPHX2L3MBTL1TPSAB1TPSD1
SCHEMBL21171925 0.84 HTT (0.67) HTTL3MBTL1LMNASMN1; SMN2TGM2
SCHEMBL24486949 0.84 HTT (0.67) HTTL3MBTL1KMT2AMEN1LMNA
SCHEMBL12409527 0.84 HTT (0.80) HTTEPHX2ALDH1A1MAPK1L3MBTL1
SCHEMBL13243335 0.83 HTT (0.54) HTTALDH1A1MAPK1L3MBTL1KMT2A
Hydrochloric Acid SCHEMBL9352205 0.82 MEN1 (0.46) HTTEPHX2ALDH1A1KMT2AMEN1
Hydrochloric Acid SCHEMBL9352193 0.82 MEN1 (0.46) HTTEPHX2ALDH1A1KMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0832076-A1 NOVEL ISOXAZOLINE AND ISOXAZOLE FIBRINOGEN RECEPTOR ANTAGONISTS THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) 1998-04-01 EP disclosed